Latest News of ARVN
Arvinas (NASDAQ:ARVN) shareholders have endured a 74% loss from investing in the stock three years ago
By Yahoo! Finance |
2 months ago
Arvinas, Inc. (NASDAQ: ARVN) has seen a significant 74% drop in share price over three years. Despite strong revenue growth, the lack of profitability raises concerns about the company's future perfor...
Arvinas, Inc. (ARVN): This Small-Cap Healthcare Stock Is A Good Buy Right Now
By Yahoo! Finance |
2 months ago
The article discusses the top small-cap healthcare stocks to invest in, focusing on Arvinas, Inc. (NASDAQ:ARVN), a biopharmaceutical company specializing in protein degradation therapeutics....
ARVN Stock Price | Arvinas Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch |
3 months ago
Arvinas, Inc. is a biopharmaceutical company focusing on developing therapies to degrade disease-causing proteins. Their product candidates include ARV-110, ARV-471, and ARV-766 targeting specific pro...
-
Brokers Are Upgrading Their Views On Arvinas, Inc. (NASDAQ:ARVN) With These New Forecasts
By Yahoo! Finance | 3 months agoArvinas, Inc. (NASDAQ:ARVN) saw analysts upgrading their forecasts, anticipating substantial growth in revenues and earnings per share. Predictions include a 131% increase in sales by 2024 and a 34% r...
-
Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy Rating?
By Yahoo! Finance | 5 months agoDiscover the top 10 small-cap stocks with high growth potential, including Arvinas, Inc. (NASDAQ: ARVN). Learn about the benefits and risks of investing in small-cap stocks and how they compare to lar...